Public Citizen comments on user fees
This article was originally published in The Gray Sheet
"Medical Device User Fee and Modernization Act" will put "pressure" on FDA to give more weight to industry's interest in speedy approvals than the "public's need for protection from dangerous devices," the watchdog group asserts Oct. 18. "A desire for repeat business on the part of inspectors and reviewers will give them an incentive to go easy on manufacturers" undergoing third-party inspection, the group notes...
You may also be interested in...
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.
A lower first dose boosted the vaccine’s efficacy result, but AstraZeneca has conceded that this has to be proven in a separate trial. In the meantime, the UK government has asked the regulator to assess the vaccine under a special health emergency provision.